I would like to learn more about how healthcare professionals in the hepatology and endocrinology fields manage patients with Metabolic dysfunction-associated steatohepatitis (MASH) and the progression of liver fibrosis in the United States. In particular, I am interested in better understanding the diagnostic tools that Hepatologists, Gastroenterologists, Clinical Pathologists, and Endocrinologists utilize for diagnosing MASH and monitoring liver fibrosis stages. Additionally, I am curious about the gaps and limitations in the current diagnostic approaches for MASH patients and how public health experts and researchers in hepatology are working to address these challenges.

Learn More